跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
查看斯高帕斯 (Scopus) 概要
林 聖軒
教授
統計學研究所
https://orcid.org/0000-0003-0714-2354
h-index
h10-index
h5-index
1755
引文
20
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1229
引文
16
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
356
引文
11
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2010
2026
每年研究成果
概覽
指紋
網路
計畫
(11)
研究成果
(88)
獎項
(4)
類似的個人檔案
(6)
指紋
查看啟用 Sheng-Hsuan Lin 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Mediation Analysis
100%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
69%
Causal Mediation Analysis
64%
Taiwan
63%
Causal Effect
62%
Smartphone Addiction
59%
Diabetic Foot
57%
Mobile Application
47%
Failure Rate
47%
Medical Internship
46%
Hospitalization Risk
46%
Heart Failure Hospitalization
46%
Retrospective Analysis
46%
Amputation Rate
46%
National Cohort Study
46%
Incretin-based Therapy
46%
Risk Factors
40%
Periprosthetic Joint Infection
40%
Parkinson's Disease
37%
Survival Outcomes
36%
Phantom Ringing
34%
Phantom Vibration
34%
Reimplantation
34%
COVID-19
34%
Hsinchu
34%
Exchange Arthroplasty
34%
Type 2 Diabetic Patients
32%
Stay-at-home Behavior
32%
Mechanistic Interaction
31%
Reinfection
31%
Internship
30%
G-formula
30%
Smartphone Use
29%
Path Dependence
29%
Knee Arthroplasty
28%
Sufficient Component Cause Model
28%
Time-varying Exposure
26%
Causal Mechanisms
26%
Hepatocellular Carcinoma
26%
Knee
26%
Time-varying Confounders
24%
Working Hours
24%
Arthroplasty Outcomes
24%
Total Knee Arthroplasty
24%
Natural Indirect Effect
24%
Thyroid Surgery
23%
Prognostic Implications
23%
Total Component
23%
Intraoperative Cultures
23%
Genitourinary Infection
23%
Medicine and Dentistry
Periprosthetic Joint Infection
54%
Amputation
47%
Reinfection
41%
Knee
40%
Arthroplasty
37%
Mediator
36%
Total Knee Arthroplasty
36%
Retrospective Study
35%
Sodium Glucose Cotransporter 2 Inhibitor
34%
Thyroid Surgery
34%
Incretin
34%
Foot Disease
34%
Congestive Heart Failure
34%
Medical Nutrition Therapy
34%
Infection
34%
Diabetes Mellitus
33%
Sodium-Glucose Cotransporter 2 Inhibitors
28%
Thyroidectomy
27%
Patient with Type 2 Diabetes
25%
Retrospective Cohort Study
24%
Decision Making
23%
Urinary Tract Infection
23%
Traditional Chinese Medicine
23%
Role Playing
23%
Recurrent Laryngeal Nerve
19%
Excision Arthroplasty
19%
Replantation
18%
Neuromonitoring
17%
Cerebrovascular Disease
15%
Diseases
15%
Knee Arthroplasty
14%
Antibiotics
14%
Antimicrobial Agent
14%
COVID-19
13%
Revision Arthroplasty
13%
Diabetes
13%
Survival Rate
11%
Cardiovascular Disease
11%
Medicine
11%
Glucagon-Like Peptide-1 Agonist
11%
Atmospheric Aerosol
11%
Pancreas Adenocarcinoma
11%
Restylane
11%
Glycemic
11%
Life Expectancy
11%
Two-Stage Revision
11%
Drug Sensitivity
11%
Standardized Mortality Ratio
11%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
Triple Negative Breast Cancer
11%
